ClinicalTrials.gov
ClinicalTrials.gov Menu

Follow-up Study on Recipients of Treatment at the Jerusalem Center for the Treatment of Psychotrauma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00463138
Recruitment Status : Completed
First Posted : April 20, 2007
Last Update Posted : September 4, 2013
Sponsor:
Information provided by (Responsible Party):
Dr. Ruth Pat-Horenzcyk, Herzog Hospital

Brief Summary:
Researchers examined perceived satisfaction and perceived increase or decrease in symptoms among recipients of treatment at the Jerusalem Center for the Treatment of Psychotrauma, using self report methods. Researchers hypothesized that a significant number of recipients would report a decrease in their symptoms and general satisfaction with the treatment they received.

Condition or disease Intervention/treatment
Healthy Behavioral: Crisis intervention

Detailed Description:
Researchers conducted a follow-up study of clients of Meytiv, the clinical branch of the Jerusalem Center for the Treatment of Psychotrauma. Researchers plan to use the results of the study to better understand the demographics of those who come to the Center, and to improve the services offered to our clients. Before beginning treatment, every Meytiv client filled out a questionnaire in which information is requested regarding demographics, trauma history, symptoms, and various levels of functioning. Researchers administered a similar self-report questionnaire to all clients upon completion of treatment. The follow-up questionnaire contained the following several indices: the Traumatic Events Screening Inventory (TESI), which requests a client's trauma history; the Multidimensional Scale of Perceived Social Support, which measures level of family, friend, and other support; the Brief Symptom Inventory, which measures level of various psychiatric symptoms, including somatic complaints, depressive symptoms, anxiety, and paranoid or hostile thoughts; the Self-Efficacy Scale, which measures level of self-reliance and confidence in one's ability to cope with stressors; and PDS, which measures subjective response to trauma, symptoms, and and level of functioning. This questionnaire, which mirrors one completed by all Meytiv's clients before treatment, was administered to those clients who completed treatment within a year of the study. Clients completed the follow-up questionnaire on condition that if they were in need of further treatment, Meytiv would refer them to the appropriate provider. Responses will be coded and analyzed to check significance among potentially related variables, including demographic variables. Most importantly, results of the follow-up questionnaire will be compared to its parallel from the beginning of treatment in order to examine what effects our treatment has on one's symptoms, and whether our clients have been satisfied

Study Type : Observational
Actual Enrollment : 100 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Follow-up Study on Recipients of Treatment at the Jerusalem Center for the Treatment of Psychotrauma
Study Start Date : April 2007
Actual Primary Completion Date : March 2008
Actual Study Completion Date : March 2008



Primary Outcome Measures :
  1. depressive symptoms, anxiety, PDS, which measures subjective response to trauma, symptoms, and and level of functioning. [ Time Frame: April 2007- March 2008 ]

Secondary Outcome Measures :
  1. level of family, friend, and other support, Self-Efficacy Scale [ Time Frame: Aprol 2007- March2008 ]

Other Outcome Measures:
  1. Traumatic Events Screening Inventory (TESI) [ Time Frame: April 2008- March 2008 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
All clients who were exposed to a traumatic event within the last 2 years and completed treatment at the Trauma Center within the last year
Criteria

Inclusion Criteria:

  • All clients who were exposed to a traumatic event within the last 2 years and completed treatment at the Trauma Center within the last year

Exclusion Criteria:

  • Clients under the age of 12

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00463138


Sponsors and Collaborators
Herzog Hospital
Investigators
Principal Investigator: Danny Brom, Ph.D Israel Center for the Treatment of Psychotrauma

Responsible Party: Dr. Ruth Pat-Horenzcyk, Research director, Herzog Hospital
ClinicalTrials.gov Identifier: NCT00463138     History of Changes
Other Study ID Numbers: Brom3CTIL
First Posted: April 20, 2007    Key Record Dates
Last Update Posted: September 4, 2013
Last Verified: September 2013

Keywords provided by Dr. Ruth Pat-Horenzcyk, Herzog Hospital:
perceived increase or decrease in symptoms post treatment
Satisfaction with the treatment